Strs Ohio Spero Therapeutics, Inc. Transaction History

Strs Ohio

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 25, 2021	SELL	$11.65 - $22.07 $82,715 - $156,697	-7,100 Closed	0 $0
Q2 2020 Jul 23, 2020	BUY	$7.27 - $14.18 $51,617 - $100,678	7,100 New	7,100 $96,000
Q4 2018 Jan 23, 2019	SELL	$5.69 - $11.28 $0 - $0	0 Closed	0 $0
Q3 2018 Oct 19, 2018	SELL	$9.69 - $17.79 $16,473 - $30,243	-1,700 Closed	0 $0
Q4 2017 Jan 23, 2018	BUY	$10.43 - $14.75 $17,731 - $25,075	1,700	1,700 $19,000

14.9M

200

200

Ticker SPRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,067,500
Market Cap $28.8M
Description
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.